Cite
HARVARD Citation
Jacobsen, E. et al. (n.d.). Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma. Leukemia & lymphoma. 56 (4), pp. 993-998. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jacobsen, E. et al. (n.d.). Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma. Leukemia & lymphoma. 56 (4), pp. 993-998. [Online].